Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital, is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College and Chinese Academy of Medical Sciences.

During the past decade, Peking Union Medical College Hospital conducted 746 clinical trials. In the 10-year time frame, 746 clinical trials started and 65 clinical trials were completed, i.e. on average, 8.7% percent of trials that started reached the finish line to date. In the past 5 years, 440 clinical trials started and 44 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peking Union Medical College Hospital" #1 sponsor was "Peking Union Medical College Hospital" with 402 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 21 trials sponsored, "BeiGene" with 19 trials sponsored, "Boehringer Ingelheim" with 17 trials sponsored and "Takeda" with 17 trials sponsored. Other sponsors include 413 different institutions and companies that sponsored additional 219 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peking Union Medical College Hospital" #1 collaborator was "Peking Union Medical College Hospital" with 37 trials as a collaborator, "Peking University First Hospital" with 16 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 14 trials as a collaborator, "Beijing Tiantan Hospital" with 10 trials as a collaborator and "Peking University People's Hospital" with 10 trials as a collaborator. Other collaborators include 899 different institutions and companies that were collaborators in the rest 498 trials.

According to Clinical.Site data, the most researched conditions in "Peking Union Medical College Hospital" are "Breast Cancer" (27 trials), "Multiple Myeloma" (17 trials), "Non-small Cell Lung Cancer" (12 trials), "Rheumatoid Arthritis" (11 trials) and "Differentiated Thyroid Cancer" (9 trials). Many other conditions were trialed in "Peking Union Medical College Hospital" in a lesser frequency.

Most popular intervention types in "Peking Union Medical College Hospital" are "Drug" (585 trials), "Other" (77 trials), "Procedure" (53 trials), "Device" (51 trials) and "Biological" (38 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (96 trials), "Anlotinib" (17 trials), "placebo" (13 trials), "Dexamethasone" (11 trials) and "Tislelizumab" (11 trials). Other intervention names were less common.

The vast majority of trials in "Peking Union Medical College Hospital" are 754 trials for "All" genders, 116 trials for "Female" genders and 23 trials for "Male" genders.

Currently, there are 358 active trials in "Peking Union Medical College Hospital". 30 are not yet recruiting, 250 are recruiting, 73 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 259 completed trials in Peking Union Medical College Hospital, 3 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Peking Union Medical College Hospital, 92 "Phase 1" clinical trials were conducted, 208 "Phase 2" clinical trials and 213 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 78 trials, and there were also 145 trials that are defined as “Not Applicable".